These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 38364330)
1. The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage. Cai Y; Chen M; Ye F; Liu Z; Luo S; Huang L; Kang L Eur J Surg Oncol; 2024 Apr; 50(4):108001. PubMed ID: 38364330 [TBL] [Abstract][Full Text] [Related]
2. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial. Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X; BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964 [TBL] [Abstract][Full Text] [Related]
3. The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0. Cui Y; Liu X; Li S; Wang H; Xiang Y; Zhang Y; Song M; Geng J; Liu Z; Teng H; Zhu X; Cai Y; Li Y; Wang W Clin Transl Oncol; 2024 Apr; 26(4):1012-1021. PubMed ID: 38051436 [TBL] [Abstract][Full Text] [Related]
4. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center. Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403 [TBL] [Abstract][Full Text] [Related]
5. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study. Liao YT; Lin YL; Huang J; Hung JS; Lin BR Int J Colorectal Dis; 2021 Mar; 36(3):509-516. PubMed ID: 33128083 [TBL] [Abstract][Full Text] [Related]
6. The Prognostic Effects of Clinicopathological Features on Rectal Cancer Patients undergoing Neoadjuvant Chemoradiotherapy. Arslan A; Akay E; Turk G; Eren SK J Coll Physicians Surg Pak; 2021 Apr; 31(4):422-428. PubMed ID: 33866728 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy. Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453 [TBL] [Abstract][Full Text] [Related]
8. Effect of adjuvant chemotherapy on the oncological outcome of rectal cancer patients with pathological complete response. Yang J; Deng Q; Cheng Y; Fu Z; Wu X World J Surg Oncol; 2024 Jan; 22(1):31. PubMed ID: 38273352 [TBL] [Abstract][Full Text] [Related]
9. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy]. You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061 [TBL] [Abstract][Full Text] [Related]
10. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial]. Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918 [No Abstract] [Full Text] [Related]
11. [Postoperative pathological staging correlates the prognosis of rectal cancer after neoadjuvant chemoradiotherapy]. Xiao Y; Lu J; Xiong G; Wu B; Lin G; Zhao L; Liang Z; Zhong G; Hu K; Pan W; Qiu H Zhonghua Wai Ke Za Zhi; 2014 Feb; 52(2):99-104. PubMed ID: 24809516 [TBL] [Abstract][Full Text] [Related]
12. Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model. Sun Y; Wu X; Lin H; Lu X; Huang Y; Chi P J Gastrointest Surg; 2021 Apr; 25(4):1019-1028. PubMed ID: 32219686 [TBL] [Abstract][Full Text] [Related]
13. Oncologic benefit of adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and curative surgery with selective lateral pelvic lymph node dissection: An international retrospective cohort study. Fukui Y; Hida K; Hoshino N; Song SH; Park SY; Choi GS; Maeda Y; Matoba S; Kuroyanagi H; Bae SU; Jeong WK; Baek SK; Sakai Y Eur J Surg Oncol; 2022 Jul; 48(7):1631-1637. PubMed ID: 35153105 [TBL] [Abstract][Full Text] [Related]
14. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report]. Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308 [No Abstract] [Full Text] [Related]
15. T-stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics. Hayes IP; Milanzi E; Pelly RM; Gibbs P; Reece JC J Surg Oncol; 2022 Sep; 126(4):728-739. PubMed ID: 35635190 [TBL] [Abstract][Full Text] [Related]
16. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study. Seddik Y; Brahmi SA; Afqir S Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979 [TBL] [Abstract][Full Text] [Related]
17. Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal Cancer: A Post Hoc Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. Diefenhardt M; Ludmir EB; Hofheinz RD; Ghadimi M; Minsky BD; Rödel C; Fokas E JAMA Oncol; 2020 Sep; 6(9):1416-1421. PubMed ID: 32644104 [TBL] [Abstract][Full Text] [Related]
18. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer. Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577 [TBL] [Abstract][Full Text] [Related]
19. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery. Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M; JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study. Okuyama T; Sameshima S; Takeshita E; Yoshioka R; Yamagata Y; Ono Y; Tagaya N; Noie T; Oya M World J Surg Oncol; 2018 Jun; 16(1):105. PubMed ID: 29871650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]